Targeted deletion of PD-1 in myeloid cells induces antitumor immunityLaura Strauss, Vassiliki A. Boussiotis, Mohamed A. A. Mahmoud et al.|Science Immunology|2020Cited by 448
Clinical significance of T cell metabolic reprogramming in cancerChristoph Herbel, Vassiliki A. Boussiotis, Nikolaos Patsoukis et al.|Clinical and Translational Medicine|2016Cited by 95
Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune ResponsesNikolaos Patsoukis, Vassiliki A. Boussiotis, Jessica D. Weaver et al.|Frontiers in Immunology|2017Cited by 53
The role of metabolic reprogramming in T cell fate and function.Nikolaos Patsoukis, Vassiliki A. Boussiotis, Kankana Bardhan et al.|PubMed|2016Cited by 43
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cellsKankana Bardhan, Vassiliki A. Boussiotis, Halil‐Ibrahim Aksoylar et al.|Scientific Reports|2019Cited by 40